Characterisation of vaccine-induced, broadly cross-reactive IFN-γ secreting T cell responses that correlate with rapid protection against classical swine fever virus

Vaccine

Volumn 30, Issue 17, 2012, Pages 2742-2748

  Graham, Simon P ^a   Haines, Felicity J ^a   Johns, Helen L ^a,c   Sosan, Olubukola ^a   La Rocca, S Anna ^a   Lamp, Benjamin ^b   Rümenapf, Till ^b   Everett, Helen E ^a   Crooke, Helen R ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Classical swine fever virus; Interferon ; Swine; T cells; Vaccination and infection

Indexed keywords

ANTIVIRUS AGENT; GAMMA INTERFERON; INFLUENZA VACCINE; VIRUS PROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS REACTION; GENOTYPE; IN VITRO STUDY; MALE; NONHUMAN; PEPTIDE LIBRARY; PESTIVIRUS; PHENOTYPE; PRIORITY JOURNAL; SWINE; T LYMPHOCYTE; VIRUS ISOLATION;

AMINO ACID SEQUENCE; ANIMALS; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; CROSS REACTIONS; EPITOPES; INTERFERON-GAMMA; MALE; MOLECULAR SEQUENCE DATA; SWINE; T-LYMPHOCYTES; VACCINES, ATTENUATED; VIRAL PROTEINS; VIRAL VACCINES;

EID: 84858708796     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.02.029     Document Type: Article

References (29)

1. van Oirschot J.T. Emergency vaccination against classical swine fever. Dev Biol (Basel) 2003, 114:259-267.
2. Vandeputte J., Chappuis G. Classical swine fever: the European experience and a guide for infected areas. Rev Sci Technol 1999, 18:638-647.
3. van Oirschot J.T. Vaccinology of classical swine fever: from lab to field. Vet Microbiol 2003, 96:367-384.
4. Suradhat S., Intrakamhaeng M., Damrongwatanapokin S. The correlation of virus-specific interferon-gamma production and protection against classical swine fever virus infection. Vet Immunol Immunopathol 2001, 83:177-189.
5. Suradhat S., Damrongwatanapokin S. The influence of maternal immunity on the efficacy of a classical swine fever vaccine against classical swine fever virus, genogroup 2.2, infection. Vet Microbiol 2003, 92:187-194.
6. Ceppi M., de Bruin M.G., Seuberlich T., Balmelli C., Pascolo S., Ruggli N., et al. Identification of classical swine fever virus protein E2 as a target for cytotoxic T cells by using mRNA-transfected antigen-presenting cells. J Gen Virol 2005, 86:2525-2534.
7. Piriou L., Chevallier S., Hutet E., Charley B., Le Potier M.F., Albina E. Humoral and cell-mediated immune responses of d/d histocompatible pigs against classical swine fever (CSF) virus. Vet Res 2003, 34:389-404.
8. Rau H., Revets H., Balmelli C., McCullough K.C., Summerfield A. Immunological properties of recombinant classical swine fever virus NS3 protein in vitro and in vivo. Vet Res 2006, 37:155-168.
9. Suradhat S., Sada W., Buranapraditkun S., Damrongwatanapokin S. The kinetics of cytokine production and CD25 expression by porcine lymphocyte subpopulations following exposure to classical swine fever virus (CSFV). Vet Immunol Immunopathol 2005, 106:197-208.
10. Pauly T., Elbers K., König M., Lengsfeld T., Saalmüller A., Thiel H.J. Classical swine fever virus-specific cytotoxic T lymphocytes and identification of a T cell epitope. J Gen Virol 1995, 76:3039-3049.
11. Graham S.P., Everett H.E., Johns H.L., Haines F.J., La Rocca S.A., Khatri M., et al. Characterisation of virus-specific peripheral blood cell cytokine responses following vaccination or infection with classical swine fever viruses. Vet Microbiol 2010, 142:34-40.
12. Graham S.P., Everett H.E., Haines F.J., Johns H.L., Sosan O.A., Salguero F.J., et al. Challenge of pigs with classical swine fever viruses after C-strain vaccination reveals remarkably rapid protection and insights into early immunity. PLoS One 2012, 7:e29310.
13. Drew T.W. Classical swine fever (hog cholera). OIE manual of diagnostic tests and vaccines for terrestrial animals (mammals, birds and bees), Chapter 2.8.3, vol. 2 2008, World Organisation for Animal Health (OIE), Paris, France, pp. 1092-1106. 6th edition.
14. Everett H.E., Salguero F.J., Graham S.P., Clifford D., Nunez A., Haines F.J., et al. Characterization of experimental infection of pigs with genotype 2.1 and 3.3 isolates of classical swine fever virus. Vet Microbiol 2010, 142:26-33.
15. Xia C., Dana W., Wen-Xuea W., Jian-Qing W., Lia W., Tian-Yaoa Y., et al. Cloning and expression of interferon-α/(from a domestic porcine breed and its effect on classical swine fever virus. Vet Immunol Immunopathol 2005, 104:81-89.
16. Paton D.J., Sands J.J., Lowings J.P., Smith J.E., Ibata G., Edwards S. A proposed division of the pestivirus genus using monoclonal antibodies, supported by cross-neutralisation assays and genetic sequencing. Vet Res 1995, 26:92-109.
17. Aynaud J.M. Classical swine fever and related viral infections 1988, Martinus Nijhoff Publishers, Boston, USA, pp. 165-180.
18. Wu Z., Wang Q., Feng Q., Liu Y., Teng J., Yu A.C., et al. Correlation of the virulence of CSFV with evolutionary patterns of E2 glycoprotein. Front Biosci 2010, 2:204-220.
19. Tarradas J., Argilaguet J.M., Rosell R., Nofrarias M., Crisci E., Córdoba L., et al. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs. Vet Microbiol 2010, 142:51-58.
20. Armengol E., Wiesmüller K.H., Wienhold D., Büttner M., Pfaff E., Jung G., et al. Identification of T-cell epitopes in the structural and non-structural proteins of classical swine fever virus. J Gen Virol 2002, 83:551-560.
21. Koenig P., Lange E., Reimann I., Beer M. CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against classical swine fever virus (CSFV). Vaccine 2007, 25:3391-3399.
22. Reimann I., Depner K., Trapp S., Beer M. An avirulent chimeric pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus. Virology 2004, 322:143-157.
23. Leifer I., Lange E., Reimann I., Blome S., Juanola S., Duran J.P., et al. Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization. Vaccine 2009, 27:6522-6529.
24. de Smit A.J., Bouma A., van Gennip H.G., de Kluijver E.P., Moorman R.J. Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs. Vaccine 2001, 19:1467-1476.
25. van Gennip H.G., van Rijn P.A., Widjojoatmodjo M.N., de Smit A.J., Moormann R.J. Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response. Vaccine 2000, 19:447-459.
26. Frese M., Schwärzle V., Barth K., Krieger N., Lohmann V., Mihm S., et al. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 2002, 35:694-703.
27. Huang Y., Chen X.C., Konduri M., Fomina N., Lu J., Jin L., et al. Mechanistic link between the anti-HCV effect of interferon gamma and control of viral replication by a Ras-MAPK signaling cascade. Hepatology 2006, 43:81-90.
28. Kanda T., Steele R., Ray R., Ray R.B. Inhibition of intrahepatic gamma interferon production by hepatitis C virus nonstructural protein 5A in transgenic mice. J Virol 2009, 83:8463-8469.
29. Diaz-San Segundo F., Moraes M.P., de Los Santos T., Dias C.C., Grubman M.J. Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression. J Virol 2010, 84:2063-2077.